OPTI — OptiBiotix Health Income Statement
0.000.00%
Last trade - 00:00
- £21.66m
- £20.76m
- £0.46m
- 52
- 44
- 68
- 55
2018 November 30th | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 13 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.514 | 0.745 | 1.52 | 2.21 | 0.457 |
Cost of Revenue | |||||
Gross Profit | 0.352 | 0.393 | 0.88 | 1.12 | 0.244 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.01 | 2.91 | -1.53 | 3.58 | -10.7 |
Operating Profit | -1.5 | -2.17 | 3.05 | -1.37 | 11.1 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1.95 | -2.49 | 5.71 | 6.18 | 2.44 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.89 | -2.37 | 5.8 | 6.26 | 2.59 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -1.92 | -2.37 | 5.8 | 6.26 | 2.59 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.92 | -2.37 | 5.8 | 6.26 | 2.59 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.023 | -0.026 | 0.032 | 0.066 | -0.067 |
Dividends per Share |